Search clinical trials for: Placebo to Tolterodine

Total 60169 results

Merck Sharp & Dohme LLC

Completed

A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)

Overactive Bladder
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Astellas Pharma Inc

Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (TAURUS)

Urinary Bladder, Overactive

Canada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
Dr .S.B.PATANKAR

Completed

Study of Herbmed Plus in Ureteral Stent Discomfort

Ureteral Stent Discomfort

India
Urovant Sciences GmbH

Completed

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (Empowur)

Overactive Bladder

United States, Latvia, Hungary, Canada, Lithuania, Poland
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

Urinary Bladder, Overactive
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-8539 in Patients With Overactive Bladder

Overactive Bladder

Poland, Ukraine, Romania, Russian Federation, Czech Republic, Hungary, Netherlands, Sweden, Germany
Sanofi

Completed

MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

Overactive Bladder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

Urinary Incontinence

United Kingdom
Sanofi

Completed

SSR240600C Treatment in Women With Overactive Bladder (BILADY)

Overactive Bladder

France, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder (REMOTE)

Overactive Bladder

United States
Peking University People's Hospital

Unknown

the Indications and Clinical Efficacy of Pelvic Organ Prolapse Surgery

Pelvic Organ Prolapse

China
Pfizer

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

Overactive Bladder

Canada, United States, Costa Rica, Hungary, Slovakia, Spain, Colombia, India, Russian Federation, Ireland, Korea, Republic of, Germany, Sweden, Poland, Bulgaria, Estonia, Brazil, Greece, Latvia, Lithuania, Malaysia, Romania, Singapore, South Africa and more
KYU-SUNG LEE
Pfizer

Completed

Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients

Overactive Bladder

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) (POTTOR)

Overactive Bladder
Novartis
Procter and Gamble

Completed

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Healthy

United States
Novartis
Procter and Gamble

Completed

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Healthy

United States
Mansoura University

Completed

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

Nocturnal Incontinence
Pfizer

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Overactive Bladder

Denmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
Samsung Medical Center
Pfizer

Completed

Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder

Overactive Bladder

Korea, Republic of
Merck Sharp & Dohme LLC

Terminated

A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)

Overactive Bladder | Overactive Urinary Bladder
Urmia University of Medical Sciences

Completed

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

Disorder of Urinary Stent

Iran, Islamic Republic of
Mayo Clinic
Pfizer

Completed

Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

Health

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Cidofovir in Renal Transplant Recipients With BKVN

BK Virus (Nephropathy)

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

Urinary Bladder, Overactive

United States
Urovant Sciences GmbH

Completed

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). (Empowur)

Overactive Bladder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics and Relative Bioavailability Study

Urinary Bladder, Overactive

Singapore
Far Eastern Memorial Hospital
National Science Council, Taiwan

Completed

Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.

Lower Urinary Tract Symptoms

Taiwan
Inje University

Completed

STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study (HNF4a)

Healthy Subjects | Genotype Guided(HNF4a)
University of California, San Francisco
National Institute on Aging (NIA)

Recruiting

TReating Incontinence for Underlying Mental and Physical Health (TRIUMPH)

Overactive Bladder | Urinary Incontinence | Urinary Incontinence, Urge | Incontinence | Incontinence, Urinary | Incontinence, Urge

United States
Uroplasty, Inc

Completed

Overactive Bladder Innovative Therapy Trial (OrBIT) (OrBIT)

Overactive Bladder

United States
Chongqing Medical University
Fuling Central Hospital of Chongqing City

Unknown

Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis (ESTTFCP)

Prostatitis

China
Far Eastern Memorial Hospital

Recruiting

Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study

Female Patients With Overactive Bladder Syndrome

Taiwan
Brigham and Women's Hospital
Pfizer

Terminated

A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.

Urinary Incontinence

United States
HealthCore-NERI
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Behavior Enhances Drug Reduction of Incontinence (BE-DRI) (BE-DRI)

Urinary Incontinence (UI)

United States
elbion AG

Terminated

ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)

Overactive Bladder | Urinary Incontinence

Sweden, Germany, Poland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

Urinary Incontinence

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Urinary Incontinence

China
Pfizer's Upjohn has merged with Mylan to form Viatris...
Pfizer

Completed

Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

Urinary Incontinence
Astellas Pharma Europe B.V.

Completed

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder (Blossom)

Urinary Bladder, Overactive

Belgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
TheraVida, Inc.

Completed

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

Incontinence
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Overactive Bladder

Switzerland
National Taiwan University Hospital

Completed

Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

Antimuscarinic Drug

Taiwan
Astellas Pharma Inc

Completed

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

Urinary Bladder, Overactive

China, Taiwan, India, Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

Urinary Bladder, Overactive

Japan
Pfizer

Completed

Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

Urinary Bladder, Overactive
Università degli Studi dell'Insubria

Completed

Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity

Overactive Bladder

Italy
Noema Pharma AG

Recruiting

Basimglurant in Children, Adolescents, and Young Adults With TSC

Tuberous Sclerosis Complex

United States, India, Israel, Turkey, Italy, Poland, Spain, United Kingdom
Shanghai Institute of Acupuncture, Moxibustion...
RenJi Hospital

Completed

Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women

Urgency-frequency Syndrome

China

Search clinical trials for: Placebo to Tolterodine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations